Comparison of the clinical and laboratory data among the three genetic subgroups
Parameter . | 17p− . | VH ≥97% . | VH<97% . | P . |
---|---|---|---|---|
No. patients | 20 | 170 | 110 | |
Median age, y | 64 | 63 | 61 | .124-151 |
Male sex, % | 75 | 60 | 59 | .41‡ |
Stage, % | ||||
Binet A | 25 | 43 | 71 | <.001‡ |
Binet B | 40 | 37 | 23 | |
Binet C | 35 | 20 | 6 | |
Rai 0 | 0 | 14 | 33 | <.001‡ |
Rai 1 | 5 | 16 | 13 | |
Rai 2 | 45 | 45 | 48 | |
Rai 3 | 20 | 13 | 4 | |
Rai 4 | 30 | 12 | 4 | |
White blood count, ×109/L | 52.3 | 39.3 | 26.8 | .024-151 |
Hemoglobin, g/L | 125 | 131 | 136 | .0014-151 |
Platelet count, ×109/L | 148 | 171 | 188 | .0044-151 |
Lactate dehydrogenase, IU/L | 250 | 180 | 156 | <.0014-151 |
Alkaline phosphatase, IU/L | 159 | 127 | 117 | .0034-151 |
Albumin, g/L | 43 | 45 | 46 | .104-151 |
Splenomegaly, % | 89 | 67 | 54 | .003‡4-150 |
Mediastinal lymphadenopathy, % | 25 | 12 | 0 | <.001‡ |
Abdominal lymphadenopathy, % | 65 | 61 | 27 | <.001‡ |
Peripheral lymphadenopathy, cm24-150 | 11 | 4 | 0 | <.0014-151 |
Largest lymph node diameter, cm | 3 | 2.85 | 1 | <.0014-151 |
B symptoms, % | 37 | 20 | 8 | .001‡ |
Time from diagnosis to first treatment, mo | 3.5 | 33 | 105 | <.0014-153 |
Parameter . | 17p− . | VH ≥97% . | VH<97% . | P . |
---|---|---|---|---|
No. patients | 20 | 170 | 110 | |
Median age, y | 64 | 63 | 61 | .124-151 |
Male sex, % | 75 | 60 | 59 | .41‡ |
Stage, % | ||||
Binet A | 25 | 43 | 71 | <.001‡ |
Binet B | 40 | 37 | 23 | |
Binet C | 35 | 20 | 6 | |
Rai 0 | 0 | 14 | 33 | <.001‡ |
Rai 1 | 5 | 16 | 13 | |
Rai 2 | 45 | 45 | 48 | |
Rai 3 | 20 | 13 | 4 | |
Rai 4 | 30 | 12 | 4 | |
White blood count, ×109/L | 52.3 | 39.3 | 26.8 | .024-151 |
Hemoglobin, g/L | 125 | 131 | 136 | .0014-151 |
Platelet count, ×109/L | 148 | 171 | 188 | .0044-151 |
Lactate dehydrogenase, IU/L | 250 | 180 | 156 | <.0014-151 |
Alkaline phosphatase, IU/L | 159 | 127 | 117 | .0034-151 |
Albumin, g/L | 43 | 45 | 46 | .104-151 |
Splenomegaly, % | 89 | 67 | 54 | .003‡4-150 |
Mediastinal lymphadenopathy, % | 25 | 12 | 0 | <.001‡ |
Abdominal lymphadenopathy, % | 65 | 61 | 27 | <.001‡ |
Peripheral lymphadenopathy, cm24-150 | 11 | 4 | 0 | <.0014-151 |
Largest lymph node diameter, cm | 3 | 2.85 | 1 | <.0014-151 |
B symptoms, % | 37 | 20 | 8 | .001‡ |
Time from diagnosis to first treatment, mo | 3.5 | 33 | 105 | <.0014-153 |